BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1445927)

  • 1. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
    Singh SV; Xu BH; Maurya AK; Mian AM
    Biochim Biophys Acta; 1992 Nov; 1137(3):257-63. PubMed ID: 1445927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH; Singh SV
    Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH; Gupta V; Singh SV
    Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of mitomycin C cytotoxicity by glutathione depletion in a multi-drug resistant mouse leukemia cell line.
    Xu BH; Singh SV
    Cancer Lett; 1992 Sep; 66(1):49-53. PubMed ID: 1451095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
    Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferases and glutathione peroxidases in doxorubicin-resistant murine leukemic P388 cells.
    Singh SV; Nair S; Ahmad H; Awasthi YC; Krishan A
    Biochem Pharmacol; 1989 Oct; 38(20):3505-10. PubMed ID: 2818642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Scalamogna D; Xia H; O'Toole S; Roy D; Emerson EO; Gupta V; Zaren HA
    Int J Cancer; 1996 Mar; 65(6):852-7. PubMed ID: 8631603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate.
    Awasthi S; Srivastava SK; Ahmad F; Ahmad H; Ansari GA
    Biochim Biophys Acta; 1993 Jul; 1164(2):173-8. PubMed ID: 8329448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
    Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
    Xu BH; Gupta V; Singh SV
    Int J Cancer; 1994 Sep; 58(5):686-92. PubMed ID: 8077054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
    Rhodes T; Twentyman PR
    Br J Cancer; 1992 May; 65(5):684-90. PubMed ID: 1316774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid.
    Kuzmich S; Vanderveer LA; Walsh ES; LaCreta FP; Tew KD
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):219-24. PubMed ID: 1731759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.
    Chen G; Waxman DJ
    Biochem Pharmacol; 1995 May; 49(11):1691-701. PubMed ID: 7786310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G; Waxman DJ
    Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH; Naito M; Nakajima M; Tsuruo T
    Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C.
    Kobayashi E; Okabe M; Kono M; Arai H; Kasai M; Gomi K; Lee JH; Inaba M; Tsuruo T
    Cancer Chemother Pharmacol; 1993; 32(1):20-4. PubMed ID: 8096440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions.
    Hoban PR; Walton MI; Robson CN; Godden J; Stratford IJ; Workman P; Harris AL; Hickson ID
    Cancer Res; 1990 Aug; 50(15):4692-7. PubMed ID: 2114946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid.
    Hansson J; Berhane K; Castro VM; Jungnelius U; Mannervik B; Ringborg U
    Cancer Res; 1991 Jan; 51(1):94-8. PubMed ID: 1988111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
    Yang WZ; Begleiter A; Johnston JB; Israels LG; Mowat MR
    Mol Pharmacol; 1992 Apr; 41(4):625-30. PubMed ID: 1569917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting of mitomycin C chemotherapy.
    Nishiyama M; Suzuki K; Kumazaki T; Yamamoto W; Toge T; Okamura T; Kurisu K
    Int J Cancer; 1997 Aug; 72(4):649-56. PubMed ID: 9259406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.